UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Total Synthesis and Bioactivity Studies of Fungal Metabolite (−)-TAN-2483B

Organic letters, 2020-12, Vol.22 (24), p.9427-9432

2020

Volltextzugriff (PDF)

The MAST motional Stark effect diagnostic

Review of scientific instruments, 2010-10, Vol.81 (10), p.10D738-10D738-6

2010

Volltextzugriff (PDF)

Comparison of measured poloidal rotation in MAST spherical tokamak plasmas with neo-classical predictions

Plasma physics and controlled fusion, 2009-10, Vol.51 (10), p.105002

2009

Volltextzugriff (PDF)

2016 LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1)

Journal of hepatology, 2010, Vol.52, p.S470-S471

2010

Volltextzugriff (PDF)

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial

Journal of viral hepatitis, 2011-04, Vol.18 (4), p.e134-e143

2011

Volltextzugriff (PDF)

Synthesis and Reactivity of Discrete Europium(II) Hydride Complexes

Chemistry : a European journal, 2024-05, Vol.30 (27), p.e202400681-n/a

2024

Volltextzugriff (PDF)

Unraveling the binding mode of a methamphetamine aptamer: A spectroscopic and calorimetric study

Biophysical journal, 2022-06, Vol.121 (11), p.2193-2205

2022

Volltextzugriff (PDF)

A Structure‐Activity Investigation of the Fungal Metabolite (−)‐TAN‐2483B: Inhibition of Bruton's Tyrosine Kinase

Chemistry : a European journal, 2024-06, Vol.30 (35), p.e202401051-n/a

2024

Volltextzugriff (PDF)

High-throughput charge exchange recombination spectroscopy system on MAST

Review of scientific instruments, 2006-10, Vol.77 (10)

2006

Volltextzugriff (PDF)

11 SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS

Journal of hepatology, 2012-04, Vol.56, p.S6-S6

2012

Volltextzugriff (PDF)

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1195-1206

2011

Volltextzugriff (PDF)

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1207-1217

2011

Volltextzugriff (PDF)

Experimental investigation into ELM filament formation on MAST

Plasma physics and controlled fusion, 2007-09, Vol.49 (9), p.1431-1446

2007

Volltextzugriff (PDF)

478 INFECTIONS DURING PEGINTERFERON (PEGIFN)/RIBAVIRIN (RBV) THERAPY ARE ASSOCIATED WITH THE MAGNITUDE OF DECLINE IN THE LYMPHOCYTE COUNT: RESULTS OF THE IDEAL STUDY

Journal of hepatology, 2011-03, Vol.54, p.S195-S196

2011

Volltextzugriff (PDF)

Synthesis of Bioactive Side‐Chain Analogues of TAN‐2483B

Chemistry, an Asian journal, 2019-04, Vol.14 (8), p.1230-1237

2019

Volltextzugriff (PDF)

991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY

Journal of hepatology, 2008, Vol.48, p.S370-S371

2008

Volltextzugriff (PDF)

127 PHOSPHODIESTERASE POLYMORPHISMS MAY BE ASSOCIATED WITH BASELINE THYROID STIMULATING HORMONE (TSH) AND PEGINTERFERON TREATMENT INDUCED HYPOTHYROIDISM IN PATIENTS WITH CHRONIC HEPATITIS C

Journal of hepatology, 2011-03, Vol.54, p.S56-S56

2011

Volltextzugriff (PDF)

304 METABOLIC SYNDROME (MS) IS A NEGATIVE PREDICTOR OF TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE IDEAL STUDY

Journal of hepatology, 2010, Vol.52, p.S127-S128

2010

Volltextzugriff (PDF)

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

JAMA : the journal of the American Medical Association, 2015-05, Vol.313 (17), p.1728

2015

Volltextzugriff (PDF)

126 HEMOGLOBIN DECLINE IS ASSOCIATED WITH SVR AMONG HCV GENOTYPE 1-INFECTED PERSONS TREATED WITH PEGINTERFERON (PEG)/RIBAVIRIN (RBV): ANALYSIS FROM THE IDEAL STUDY

Journal of hepatology, 2009, Vol.50, p.S51-S52

2009

Volltextzugriff (PDF)

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

Journal of hepatology, 2009, Vol.50, p.S4-S4

2009

Volltextzugriff (PDF)

Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic Whites

The New England journal of medicine, 2004-05, Vol.350 (22), p.2265-2271

2004

Volltextzugriff (PDF)

995 INTERIM RESULTS FROM HCV SPRINT-1: RVR/EVR FROM PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRONTM (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHC

Journal of hepatology, 2008, Vol.48, p.S372-S372

2008

Volltextzugriff (PDF)

Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial

Hepatology (Baltimore, Md.), 2013-03, Vol.57 (3), p.974-984

2013

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(74)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(24)
Humans
(21)
Female
(20)
Male
(19)
Gastroenterology And Hepatology
(18)
Middle Aged
(17)
Adult
(15)
Hepatitis C, Chronic - Drug Therapy
(14)
Biological And Medical Sciences
(11)
Hepacivirus - Genetics
(11)
Infectious Diseases
(11)
Genotype
(10)
Medical Sciences
(10)
Antiviral Agents - Adverse Effects
(9)
Drug Therapy, Combination
(9)
Hepatitis
(9)
Physical Sciences
(9)
Recombinant Proteins
(9)
Treatment Outcome
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Total Synthesis and Bioactivity Studies of Fungal Metabolite (−)-TAN-2483B

The MAST motional Stark effect diagnostic

Comparison of measured poloidal rotation in MAST spherical tokamak plasmas with neo-classical predictions

2016 LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1)

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial

Synthesis and Reactivity of Discrete Europium(II) Hydride Complexes

Unraveling the binding mode of a methamphetamine aptamer: A spectroscopic and calorimetric study

A Structure‐Activity Investigation of the Fungal Metabolite (−)‐TAN‐2483B: Inhibition of Bruton's Tyrosine Kinase

High-throughput charge exchange recombination spectroscopy system on MAST

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

11 SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Experimental investigation into ELM filament formation on MAST

478 INFECTIONS DURING PEGINTERFERON (PEGIFN)/RIBAVIRIN (RBV) THERAPY ARE ASSOCIATED WITH THE MAGNITUDE OF DECLINE IN THE LYMPHOCYTE COUNT: RESULTS OF THE IDEAL STUDY

Synthesis of Bioactive Side‐Chain Analogues of TAN‐2483B

991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY

127 PHOSPHODIESTERASE POLYMORPHISMS MAY BE ASSOCIATED WITH BASELINE THYROID STIMULATING HORMONE (TSH) AND PEGINTERFERON TREATMENT INDUCED HYPOTHYROIDISM IN PATIENTS WITH CHRONIC HEPATITIS C

304 METABOLIC SYNDROME (MS) IS A NEGATIVE PREDICTOR OF TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE IDEAL STUDY

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

126 HEMOGLOBIN DECLINE IS ASSOCIATED WITH SVR AMONG HCV GENOTYPE 1-INFECTED PERSONS TREATED WITH PEGINTERFERON (PEG)/RIBAVIRIN (RBV): ANALYSIS FROM THE IDEAL STUDY

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic Whites

995 INTERIM RESULTS FROM HCV SPRINT-1: RVR/EVR FROM PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRONTM (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHC

Anemia during treatment with peginterferon Alfa‐2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT‐2) trial

Suchergebnisse filtern